ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 361605 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 361605; 2) Community: the network communities that were significantly associated with the response to NSC 361605; 3) Molecule: the relationships between components within communities and NSC 361605; 4) MDR: the compounds that were significantly associated with the NSC 361605.

NSC Compound Enrichment Correlation
NSC 710546 Null 0.0133299224082803 0.30167563
NSC 715584 Null 0.0133299224082803 0.093974695
NSC 724058 3-[(N,N-Dimethylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-8 ,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0133299224082803 0.46976692
NSC 725670 5,6-Dihydro-5,11-dioxo-6-(2-N-piperazine-1-ethyl)-11H-indeno [1,2-c]isoquinoline 0.0133299224082803 0.27126497
NSC 727987 NSC 708783 incorporated in micelles, 0.20% (w/w) of drug 0.0133299224082803 0.065036778
NSC 737225 Null 0.0133299224082803 0.36163853
NSC 752461 Null 0.0133299224082803 0.24905721
NSC 754240 2,9-dimethoxy-6-(2-(piperidin-1-yl)ethoxy)-11H-indeno[1,2-c]quinolin-11-one 0.0133299224082803 0.35037762
NSC 756170 GSK317315A 0.0133299224082803 0.14653666
NSC 529108 4-Fluoro-D,L-tryptophan 0.0133986477026051 0.22236075
Total:79  Current:29    [First] [Prev] [Next] [Last]